Since a previous study found a significant reduction in the levels of drd3-transcripts in PBMCs obtained from PD (24), we addressed here the question of whether DRD3 expression, at the level of protein, was altered in CD4+ T-cells obtained from PD patients. This evidence concerns the gene CD4 and Parkinson disease.